0001959255-22-000001.txt : 20221221 0001959255-22-000001.hdr.sgml : 20221221 20221221132049 ACCESSION NUMBER: 0001959255-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221221 DATE AS OF CHANGE: 20221221 EFFECTIVENESS DATE: 20221221 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Protillion Biosciences, lnc. CENTRAL INDEX KEY: 0001959255 IRS NUMBER: 841877512 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-468247 FILM NUMBER: 221477594 BUSINESS ADDRESS: STREET 1: 1400 MARSTEN RD. STE. M CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 801-592-4108 MAIL ADDRESS: STREET 1: 1400 MARSTEN RD. STE. M CITY: BURLINGAME STATE: CA ZIP: 94010 D 1 primary_doc.xml X0708 D LIVE 0001959255 Protillion Biosciences, lnc. 1400 MARSTEN RD. STE. M BURLINGAME CA CALIFORNIA 94010 801-592-4108 DELAWARE None None Corporation true 2019 Curtis Layton c/o Protillion Biosciences, lnc. 1400 Marsten Rd. Ste. M Burlingame CA CALIFORNIA 94010 Executive Officer Director Sean Kendall c/o Protillion Biosciences, lnc. 1400 Marsten Rd. Ste. M Burlingame CA CALIFORNIA 94010 Director Malek Faham c/o Protillion Biosciences, lnc. 1400 Marsten Rd. Ste. M Burlingame CA CALIFORNIA 94010 Director David Walt c/o Protillion Biosciences, lnc. 1400 Marsten Rd. Ste. M Burlingame CA CALIFORNIA 94010 Director Other Decline to Disclose 06b false 2022-12-06 false true false 0 20669994 19003328 1666666 Series A-1 Preferred Stock, Series A-2 Preferred Stock and the Common Stock issuable upon conversion thereof. false 9 0 0 0 false Protillion Biosciences, lnc. /s/ Curtis Layton Curtis Layton Chief Executive Officer 2022-12-21